🚨 Everything is back in stock — all peptides available now 🚨
Shop/Performance & Vitality
Performance & Vitality

PT-141 · 10 mg

A melanocortin receptor agonist — the same peptide family as Melanotan. It acts on MC4R in the brain rather than on blood vessels, which is why it is approved for sexual desire, not erections. In the US it is a prescription medicine, Vyleesi.

Read the research on PT-141
Lab-verified · Same-day Bali delivery · Pay on delivery
Format
Total
Rp 1.050.000
1

Includes 10× sterile insulin syringes + 1 vial of bacteriostatic water, free with your order.

Complete your kit

Insulin Syringes
Insulin Syringes
1 unit
Rp 7.000
Alcohol Prep Swabs
Alcohol Prep Swabs
1 unit
Rp 1.000
Insulated Travel Case
Insulated Travel Case
Hard case
Rp 150.000
AVERON Peptide Pen — V2 Aluminium
AVERON Peptide Pen — V2 Aluminium
Colour: Black
Rp 950.000

For research and educational use only. Not for human or veterinary consumption.

What the approved use shows, in women:

  • It raises sexual desire and lowers the distress around it. In two phase 3 trials (about 1,250 premenopausal women with hypoactive sexual desire disorder), bremelanotide beat placebo on both desire and distress scores. The effect was real but modest.
  • It is taken on demand, about 45 minutes before, not every day — the opposite of a daily pill.

What the earlier research and community use show:

  • It works through the brain, not blood flow. That is the mechanistic reason people reach for it when flow-based drugs aren't the issue, or aren't enough.
  • Onset is roughly 30–45 minutes to a few hours, and the effect can carry over for several hours.
  • Men were studied too, in phase 1/2 erectile-dysfunction trials in the 2000s, before that program was stopped — see Studies & references for why.

It is not an erection drug and not a replacement for one. The approved effect is on desire in women. The male erectile-dysfunction program was discontinued in 2008; it is not approved for men anywhere.

It does not fix a relationship or a medication side effect. The trials excluded desire problems caused by relationship issues or by other drugs, because it doesn't address those.

It is not a daily tonic. The label caps use at one dose in 24 hours and eight doses a month. More is not better — it is more nausea and more blood-pressure rise.

This vial is not Vyleesi. Vyleesi is a sterile single-dose autoinjector dispensed on prescription. What we supply is research-grade bremelanotide powder — the same molecule, a different product, with no approval for men.

Very common:

  • Nausea — about 40% on the approved drug versus 1% on placebo. It is worst on the first dose (around 21%) and drops to a few percent afterwards. About 13% of trial patients needed an anti-nausea medicine, and 8% stopped because of it. Pre-treating with ondansetron did not help and isn't recommended.
  • Flushing (about 20%), headache (about 11%)

Blood pressure — read this: every dose transiently raises blood pressure (systolic by up to about 6 mmHg, diastolic by about 3) and slightly lowers heart rate, peaking 2–4 hours after the dose and settling within about 12 hours. That is why the label forbids it in uncontrolled high blood pressure or known cardiovascular disease.

With repeated use: focal hyperpigmentation — darker patches on the face, gums or breasts — was reported in about 1% at label frequency, and in 38% of people dosing daily for 8 days. It may not fully fade. More likely in darker skin. The same mole/melanoma caution as the Melanotan products applies.

Drug interaction: bremelanotide slows stomach emptying and markedly lowers the absorption of oral naltrexone — don't combine them. It can also reduce the absorption of other oral medicines taken around the same time.

Stop and see a doctor: chest pain, a severe or lasting headache, fainting, a very high blood-pressure reading, or swelling of the face, lips or throat.

🛑 Don't use it with uncontrolled hypertension, cardiovascular disease, or if pregnant or breastfeeding.

Draw past the line, tap out bubbles, push back to the line.

The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.

Maximum per injection: 100 units (1 mL)

10 mg vial + 2 mL bacteriostatic water = 5 mg/mL. Beyond the basic mix, there isn't enough reliable human data for us to publish a protocol for this use — and we won't guess one. Message us on WhatsApp and we'll share honestly what is and isn't known.

Draw past the line, tap out bubbles, push back to the line.

The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.

Maximum per injection: 100 units (1 mL)

There isn't enough reliable data for us to guide dosing for this use, so we don't publish a protocol. The only established figure is the FDA-approved 1.75 mg dose, and that was studied in women. Message us on WhatsApp before ordering and we'll talk it through honestly. Never combine it with a Melanotan product on the same day.

  • 1× PT-141 · 10 mg
  • 10× sterile insulin syringes (free)
  • 1× bacteriostatic water vial (free)
  • Compound Guide — printed, included free

Bremelanotide is approved by the FDA (2019) as Vyleesi for acquired, generalised hypoactive sexual desire disorder in premenopausal women, on the strength of two phase 3 trials. An earlier erectile-dysfunction program — including an intranasal formulation — was discontinued in 2008 after the FDA raised concerns about transient rises in blood pressure; the developer then redirected the molecule. What we supply is research-grade material, not the approved product, and it is not approved for use in men.

Athletes: bremelanotide is not named on the WADA Prohibited List. As a non-approved use in men it may still fall under S0 — check with your anti-doping agency.

Every peptide batch we sell is tested by Janoshik Analytical, an independent laboratory. Every vial carries an internal AVERON batch code identifying the lot received; each lot is linked to its published Janoshik report. The report carries the manufacturer's submission/task number, not the AVERON code. Ask us or our driver which report covers your code and open it on the laboratory's own website before paying. In our own-driver zone, the team shows you the vial and the report for that batch before payment.

A lab report handed to you by a seller and a lab report you can verify yourself are not the same thing. That's why we publish ours.

View COA on Janoshik
See also

More in Performance & Vitality

...